FactMR today unveiled its latest report on the Sleeping Aids Market, forecasting robust growth amid escalating sleep disorders, heightened stress levels, and a global push for restorative wellness solutions. Valued at USD 78.3 billion in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching USD 131.3 billion by 2035. This trajectory reflects the market's pivotal role in addressing widespread insomnia, sleep apnea, and narcolepsy, driven by urban lifestyles and an aging population seeking non-addictive, effective interventions for better health and productivity.
Full Market Report Available for Delivery. For Purchase or Customization, Please Request Here: https://www.factmr.com/connectus/sample?flag=S&rep_id=7785
Recent Developments
The sleeping aids market has witnessed transformative innovations from 2020 to 2025, accelerating with post-pandemic mental health focus. In 2024, Philips launched an AI-enhanced DreamWear mask with integrated sleep coaching, reducing apnea episodes by 25% in trials. ResMed introduced the AirSense 11 in 2023, featuring app-based adherence tracking for 1 million users. Posts on X spotlight Oura Ring's 2025 sleep stage analytics update, praised for accuracy in Abc-infused sleep aids, while Noom's 2023 behavioral therapy app for insomnia gained 500,000 downloads. These developments signal a convergence toward personalized, tech-enabled solutions, with 70% of innovations targeting non-pharmacological interventions by 2030.
Browse Full Report: https://www.factmr.com/report/sleeping-aids-market
Comments
0 comment